BridgeMD
Prevention study for Colorectal Cancer
Official title Artificial Intelligence-based Screening Models for Prevention and Early Detection of Colorectal Cancer
ClinicalTrials.gov ID: NCT06799793
What this study is testing
- What it's testing
- Colorectal cancer screening is based on the fecal occult blood test (FIT), which has low sensitivity for adenomatous polyps, based on the currently used cut-off. Risk factors such as obesity, diabetes, alcohol, and cigarette smoking are associated with the presence of high-risk neoplasia in the screening population.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 to 69
You may be able to join if
- people aged 50-69 years who underwent the fecal occult blood screening program
- Male and female sex
- Positivity to fecal occult blood (FIT) on the immunochemical screening test (OC-Sensor);the cut-off for determination of test positivity is 20...
- people who provided written consent to participate in the study.
You likely can't join if
- people who do not understand the Italian language
- people with previous history of total colectomy or bowel resections
- people with colonoscopy performed in the previous 12 months
- people with contraindications to colonoscopy
- people who have contraindication to sedation or anesthesia
- people with a personal history of CRC
See the full eligibility criteria
- people aged 50-69 years who underwent the fecal occult blood screening program
- Male and female sex
- Positivity to fecal occult blood (FIT) on the immunochemical screening test (OC-Sensor);the cut-off for determination of test positivity is 20 micrograms HgB/gr of stool (cut-off used in our country).
- people who provided written consent to participate in the study.
- people who do not understand the Italian language
- people with previous history of total colectomy or bowel resections
- people with colonoscopy performed in the previous 12 months
- people with contraindications to colonoscopy
- people who have contraindication to sedation or anesthesia
- people with a personal history of CRC
- people with hereditary gastrointestinal cancer syndrome: familial adenomatous polyposis (FAP), attenuated FAP, MutYH-associated polyposis, Lynch or Lynch-like syndrome, and serratus polyposis syndrome.
- people with inflammatory bowel disease (Crohn's disease, ulcerative colitis).
The study team makes the final eligibility decision.
Where it's taking place
- Bologna, Bologna, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years to 69 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bologna, Bologna, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.